Alyeska Investment Group, L.P. Heron Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $10 Million - $15.7 Million	-544,646 Reduced 41.26%	775,299 $21.4 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $8.37 Million - $10.7 Million	565,288 Added 74.91%	1,319,945 $23.9 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $11.1 Million - $12.7 Million	754,657	754,657 $12.2 Million

176

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $210M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.